Results from a multicenter, randomized, double-blind, placebo-controlled study of repository corticotropin injection for multiple sclerosis relapse that did not adequately respond to corticosteroids

Article (Web of Science), Early Access (Web of Science)

• cited authors: Wynn, Daniel; Goldstick, Lawrence; Bauer, William; Zhao, Enxu; Tarau, Eva; Cohen, Jeffrey A.; Robertson, Derrick; Miller, Aaron
• publication date: January 4, 2022
• webpage: Web of Science
• published in: CNS NEUROSCIENCE & THERAPEUTICS Journal
• category: PHARMACOLOGY & PHARMACY Category

keywords

• Acthar Gel
• clinical trial
• multiple sclerosis
• relapse
• repository corticotropin injection